Skip to main content

Home/ PharmaMics/ Group items tagged interest

Rss Feed Group items tagged

Alex Parker

AstraZeneca maximising innovative portfolio of non insulin anti diabetic medicines - 0 views

  •  
    AstraZeneca has completed the acquisition of Bristol-Myers Squibb's (BMS's) interests in the companies' diabetes alliance for $4.1bn.
Alex Parker

ACETO completes acquisition of PACK Pharmaceuticals - 1 views

  •  
    Published 01 May 2014 ACETO has announced that its wholly-owned subsidiary, Rising Pharmaceutical, has closed the acquisition of 100% of the equity interests of PACK Pharmaceuticals, a national marketer and distributor of generic prescription and over-the-counter pharmaceutical products. The total transaction value is approximately $100m.
1 - 3 of 3
Showing 20 items per page